Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpAfiledCriticalZambon SpA
Priority claimed from PCT/EP1985/000543external-prioritypatent/WO1986002353A1/en
Application grantedgrantedCritical
Publication of DE3564580D1publicationCriticalpatent/DE3564580D1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Dipeptides of formula (I) and their acid-addn.salts are new: NX-Y-CO is the residue of a natural amino acid selected from Gly, Ala, beta-Ala, Phe, Ile, Met, Pro, Asp and Arg; R = H or 1-4C alkyl. Specifically NX-Y-CO = Met, beta-Ala or Pro; R = 1-4C alkyl.
DE8585905404T1984-10-161985-10-16Dipeptide compounds having pharmaceutical activity and compositions containing them
ExpiredDE3564580D1
(en)
7-1-oxo-2- (substituted mercapto)-3- phenylpropyl) amino| octahydro-6-pyrido £2, 1-a| benzazepine- 4-carboxylic acid derivatives and analogs, their preparation and pharmaceutical compositions containing them for inhibiting enkephalinase and ace
Novel peptide derivatives having a nitrogenous polycyclic structure, process for the preparation thereof and pharmaceutical compositions containing them
Benzazocinone and benzazoninone derivatives, process for their preparation, pharmaceutical preparations containing these compounds, and their therapeutical use.